
[Cancer Research 41, 3967-3972, October 1, 1981]
© 1981 American Association for Cancer Research
In Vivo Kinetics of O6-Methylguanine and 7-Methylguanine Formation and Persistence in DNA of Rats Treated with Symmetrical Dimethylhydrazine1
Deborah Carlson Herron and
Ronald C. Shank2
Departments of Community and Environmental Medicine [R. C. S.] and Medical Pharmacology and Therapeutics [D. C. H.] and University of California Southern Occupational Health Center [R. C. S.], University of California, Irvine, College of Medicine, Irvine, California 92717
The rates of appearance and removal of 7-methylguanine and O6-methylguanine in DNA from rat liver, kidney, and colon were determined at various intervals up to 120 hr after i.p. administration of 10.2, 40.7, 81.5, or 163 mg 1,2-dimethylhydrazine (SDMH) per kg body weight (one-sixteenth, one-fourth, one-half, or one 50% lethal dose) using high-pressure liquid chromatography and fluorescence spectrophotometry. In most cases, increasing doses of SDMH slowed the rate of methylation of DNA, especially of the liver; colon DNA was methylated at a faster rate than was liver DNA, and kidney DNA was methylated at the slowest rate following SDMH administration. Removal of O6-methylguanine was slow (half-life, 37 to 50 hr) when this base was present in liver DNA at concentrations above 400 µmol/mol guanine; as the concentration fell below 300 µmol O6-methylguanine per mol guanine, the removal rate more than doubled (half-life, 16 to 19 hr). Some evidence was obtained to suggest that in the first 12 hr after maximum DNA methylation following SDMH administration, a rapid time-dependent removal of 7-methylguanine from liver and kidney but not colon DNA occurred. In these instances, then, the rates of formation and removal of aberrant methylated bases did not follow first-order kinetics.
1 This investigation was supported by Grant CA-21955 from the National Cancer Institute, NIH, United States Department of Health and Human Services, and by Contract F33615-76-C-5005 from the United States Air Force.
2 To whom requests for reprints should be addressed.
Received 5/12/81.
Accepted 7/14/81.
This article has been cited by other articles:

|
 |

|
 |
 
P. E. Jackson, P. J. O'Connor, D. P. Cooper, G. P. Margison, and A. C. Povey
Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine
Carcinogenesis,
March 1, 2003;
24(3):
527 - 533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Povey, A. F. Badawi, D. P. Cooper, C. N. Hall, K. L. Harrison, P. E. Jackson, N. P. Lees, P. J. O'Connor, and G. P. Margison
DNA Alkylation and Repair in the Large Bowel: Animal and Human Studies
J. Nutr.,
November 1, 2002;
132(11):
3518S - 3521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. S. Sohn, E. S. Fiala, S. P. Requeijo, J. H. Weisburger, and F. J. Gonzalez
Differential Effects of CYP2E1 Status on the Metabolic Activation of the Colon Carcinogens Azoxymethane and Methylazoxymethanol
Cancer Res.,
December 1, 2001;
61(23):
8435 - 8440.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1981 by the American Association for Cancer Research.